REFERENCES
- Breslow N, Chan CW, Dhom G, Drury RAB et al. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 1977; 20: 680–688.
- Byar DP, Mostofi FK. Carcinoma of the prostate prognostic evaluation of certain features in 208 radical prostatectomies examined by the step-section technique. Cancer 1972; 30: 5–13.
- Carter GE, Lieskowsky G, Skinner DG, Petrovich Z. Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D prostate cancer following radical prostatectomy. J Urol 1989; 142: 1266–1271.
- Elder JS, Jewett HJ, Walsh PC. Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 1982; 127: 704–706.
- Elfving P, Lundgren R. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma. Scand J Urol Nephrol, 1980; Suppl 110: 155–161.
- Epstein JI. Evaluation of radical prostatectomy capsular margins of resection: Manuscript—Personal communication, C Busch.
- Esposti PL. Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. Scand J Urol Nephrol 1971; 5: 199–209.
- Fritjofsson Å, Cederlund J, Norlén BJ, Wicklund H. Combined therapy with intestinal gold (198Au) implantation and external irradiation in the management of prostatic cancer. Scand J Urol Nephrol 1988; Suppl 110: 177–184.
- Gibbons RP, Cole BS, Richardsson RG, Correa RJ et al. Adjuvant radiotherapy following radical prostatectomy. Results and complications. J Urol 1986; 135: 65–68.
- Hodge KK, McNeal JE et al. Random systematic vs ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71–75.
- Johansson JE, Adami HO, Andersson SO et al. Natural history of localized prostatic cancer. A population based study in 223 untreated patients. Lancet 1989; i: 799–803.
- Lange PH, Narayan P. Understaging and undergrading of prostate cancer, argument for postoperative radiation as adjuvant therapy. Urology 1983; 21: 113–118.
- Madsen PO, Graversen PH, Gasser TC, Corle DK. Treatment of localized prostatic cancer. Radical prostatectomy vs placebo. A 15 year follow up. Scand J Urol Nephrol 1988; 110: 95–100.
- McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988; 12: 619–633.
- McNeal JE, Bostwick DG. Intraductal dysplasia: A premalignant lesion of the prostate. Human Pathol 1986; 17: 64.
- McNeal JE, Villers AA et al. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol 1990; 14: 240–247.
- Mostofi FK. Grading of prostatic carcinoma. Cancer chemotherapy reports, Part 1, Jan/Feb 1975; Vol 59, No. 1.
- Partin AW, Epstein JI, Cho KR et al. Morphometric measurement of tumour volume and percent of gland involvement as predictors of pathologic stage in clinical stage B prostate cancer. J Urol 1989; 141: 341–345.
- Pontes JE, Wajsman Z, Huben RP, Wolf RM, Englander LS. Prognostic factors in localized prostatic carcinoma. J Urol 1985; 134: 1137–1139.
- Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139: 1235–1241.
- UICC. TNM classification of malignant tumours. 3rd ed. Geneva, 1978: 118–121 (revised 1982).
- Walsh PC. Radical prostatectomy, preservation of sexual function, cancer control. Urol Clin N Am 1989; 14: 663–673.
- Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4: 473–485.